Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
The purpose of this study is evaluate the pharmacokinetics, pharmacodynamics, immunogenicity and anti-tumor effect of of fully human anti - VEGF monoclonal antibody LY00101 and explore the potential prognostic and predictive biomarkers. This study will not take into account the results of molecular-genetic tests of patients enrolled in the study
创建时间：
2019-04-15
